- Home
- DNTH vs FSBC Comparison
DNTH vs FSBC Comparison
Compare DNTH & FSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- FSBC
- Stock Information
- Founded
- DNTH 2015
- FSBC 2002
- Country
- DNTH United States
- FSBC United States
- Employees
- DNTH N/A
- FSBC N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- FSBC Banks
- Sector
- DNTH Health Care
- FSBC Finance
- Exchange
- DNTH Nasdaq
- FSBC Nasdaq
- Market Cap
- DNTH 568.6M
- FSBC 603.9M
- IPO Year
- DNTH N/A
- FSBC 2021
- Fundamental
- Price
- DNTH $16.86
- FSBC $26.48
- Analyst Decision
- DNTH Strong Buy
- FSBC Buy
- Analyst Count
- DNTH 8
- FSBC 4
- Target Price
- DNTH $53.00
- FSBC $34.75
- AVG Volume (30 Days)
- DNTH 277.7K
- FSBC 46.6K
- Earning Date
- DNTH 08-07-2025
- FSBC 07-23-2025
- Dividend Yield
- DNTH N/A
- FSBC 3.02%
- EPS Growth
- DNTH N/A
- FSBC N/A
- EPS
- DNTH N/A
- FSBC 2.27
- Revenue
- DNTH $6,524,000.00
- FSBC $124,973,000.00
- Revenue This Year
- DNTH N/A
- FSBC $25.86
- Revenue Next Year
- DNTH N/A
- FSBC $15.15
- P/E Ratio
- DNTH N/A
- FSBC $11.66
- Revenue Growth
- DNTH 102.36
- FSBC 11.14
- 52 Week Low
- DNTH $13.37
- FSBC $22.22
- 52 Week High
- DNTH $32.27
- FSBC $35.13
- Technical
- Relative Strength Index (RSI)
- DNTH 38.63
- FSBC 37.75
- Support Level
- DNTH $17.67
- FSBC $26.20
- Resistance Level
- DNTH $19.58
- FSBC $28.70
- Average True Range (ATR)
- DNTH 1.14
- FSBC 0.82
- MACD
- DNTH -0.07
- FSBC -0.17
- Stochastic Oscillator
- DNTH 3.20
- FSBC 9.86
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About FSBC Five Star Bancorp
Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.